LARIMAR THERAPEUTICS INC's ticker is and the CUSIP is 517125900. A total of 1 filers reported holding LARIMAR THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 200 | -96.7% | 0.00% | – |
| Q2 2023 | $19 | – | 6,100 | +6000.0% | 0.00% | – |
| Q3 2022 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 100 | -99.5% | 0.00% | – |
| Q1 2022 | $78,000 | – | 19,300 | +19200.0% | 0.00% | – |
| Q3 2021 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 100 | +4900.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 2 | -93.9% | 0.00% | – |
| Q2 2020 | $42,000 | – | 33 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |